Home/BenECO/Close the Care Gap
BenECO · Outcome Lever

Reach the conditions before they become claims.

Proactive screening, medication adherence, condition management, GLP-1 and musculoskeletal care, and specialty pharmacy access.

The Problem It Solves

Your most expensive claims were preventable eighteen months earlier.

That isn't a moral observation. It's an actuarial one. The employee who skipped the preventive visit, who didn't fill the maintenance prescription, who had no realistic way to see a clinician inside a work week — that person becomes an inpatient admission. The admission becomes your renewal.

And if you are a healthcare organization, there's a particular sting in it: the people generating those claims spend their working lives delivering care they don't receive themselves.

How the gap actually forms

There are two gaps and they compound. The first is access — whether someone can realistically see a clinician. The second is adherence — whether they do the thing the clinician told them to do.

Access fails for reasons that have nothing to do with insurance status. A night-shift nurse cannot see a primary care physician who has 9-to-5 availability and a three-week wait. A CNA earning an hourly wage does not take unpaid time off for a screening that feels optional. An employee on a high-deductible plan does the arithmetic on a $180 visit and decides it can wait until January. None of these people are uninsured. All of them are unseen.

Adherence fails downstream of that. Someone gets a diagnosis and a prescription, fills it once, and then — as the initial motivation fades, or the copay lands, or the side effects start — stops. The clinical literature on medication non-adherence is unambiguous and unflattering: a substantial share of chronic-condition patients stop taking maintenance medication within the first year . They don't tell anyone. The next signal you get is an emergency department visit.

The compounding is what makes this the most expensive lever to ignore. An unmanaged chronic condition doesn't stay flat — it escalates on a predictable curve, and every step up that curve is an order of magnitude more expensive than the one before. A $40 medication becomes a $900 ER visit becomes a $40,000 admission becomes a readmission.

Why the obvious fixes don't work

Most employers have already tried three things.

They added a telehealth benefit. Utilization is usually in the single digits. Adding a benefit is not the same as removing friction, and a benefit nobody knows about or trusts is a line item, not an intervention.

They ran a wellness campaign. Wellness programs reliably reach the people who were already going to be well. The population driving your claims spend — the disengaged, the chronically ill, the ones working two jobs — is precisely the population a step-challenge doesn't touch.

They shifted more cost to the employee. This works, in the sense that it reduces utilization. It reduces the right utilization along with the wrong kind, and the deferred care shows up eighteen months later at a higher price.

The common failure in all three is treating engagement as something the employee owes you. People with time, money, and slack engage with their health. People without those things don't — not because they don't care, but because the friction exceeds what they have available.

What actually moves the needle

Three mechanisms, in order of leverage.

Remove the friction rather than exhorting people through it. Care that reaches someone in under ten minutes, at zero copay, on the phone they already own, is used. Care that requires a PTO request, a copay, and a three-week wait is not. This is not a motivation problem.

Pay people for engaging, not for outcomes. The behavioral-economics finding that matters here is that small, frequent, loss-framed incentives work where large, distant, gain-framed ones do not. A daily check-in that pays a few dollars produces adherence that outlives the incentive. An annual premium discount produces a form nobody fills in.

Reach the people the other programs miss. The measure of an access program is not its satisfaction score among users. It is whether it engaged the quartile that was invisible before — because that quartile is where the money is.

The healthcare-employer wrinkle

If your workforce is clinical, you have a specific version of this problem that generic benefits advice doesn't address. Clinicians are famously bad patients: they self-diagnose, they defer their own care, they work through symptoms they'd hospitalize a patient for, and they're reluctant to seek behavioral or substance-use support in a profession where licensure feels like it's on the line.

They also have unusually high knowledge and unusually low availability — which means the interventions that work on them look different. Convenience matters more than education. Confidentiality matters more than incentives.

Where to start

The diagnostic looks at claims concentration, utilization by benefit, and the gap between what you offer and what gets used. In most benefit programs, a small share of members drives the majority of spend, and a meaningful part of that spend traces to care that didn't happen earlier.

That's the number BenDNA produces. Not an industry average — yours.